CN1656379A - 分析血清中酶原形式的前列腺特异抗原以提高前列腺癌检测的方法 - Google Patents

分析血清中酶原形式的前列腺特异抗原以提高前列腺癌检测的方法 Download PDF

Info

Publication number
CN1656379A
CN1656379A CNA038119021A CN03811902A CN1656379A CN 1656379 A CN1656379 A CN 1656379A CN A038119021 A CNA038119021 A CN A038119021A CN 03811902 A CN03811902 A CN 03811902A CN 1656379 A CN1656379 A CN 1656379A
Authority
CN
China
Prior art keywords
psa
ppsa
free
cancer
total
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038119021A
Other languages
English (en)
Chinese (zh)
Inventor
史蒂芬·D·米科瓦伊奇克
哈里·G·里滕豪斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of CN1656379A publication Critical patent/CN1656379A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CNA038119021A 2002-05-24 2003-05-22 分析血清中酶原形式的前列腺特异抗原以提高前列腺癌检测的方法 Pending CN1656379A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/154,715 US20030219840A1 (en) 2002-05-24 2002-05-24 Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection
US10/154,715 2002-05-24

Publications (1)

Publication Number Publication Date
CN1656379A true CN1656379A (zh) 2005-08-17

Family

ID=29548943

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038119021A Pending CN1656379A (zh) 2002-05-24 2003-05-22 分析血清中酶原形式的前列腺特异抗原以提高前列腺癌检测的方法

Country Status (5)

Country Link
US (1) US20030219840A1 (https=)
EP (1) EP1506401A4 (https=)
JP (1) JP2006508332A (https=)
CN (1) CN1656379A (https=)
WO (1) WO2003100079A2 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102520161A (zh) * 2012-01-05 2012-06-27 中南大学 一种用于spr双通道法检测前列腺特异性抗原的生物传感芯片、试剂盒，检测方法
CN103134929A (zh) * 2011-12-02 2013-06-05 沃克(天津)生物科技有限公司 游离前列腺特异抗原与总前列腺特异抗原一体化酶联免疫检测试剂盒及检测方法
CN105929151A (zh) * 2016-06-30 2016-09-07 深圳市亚辉龙生物科技股份有限公司 前列腺特异性抗原同源异构体化学发光免疫检测试剂盒及其制备方法
CN111596060A (zh) * 2020-05-19 2020-08-28 迪瑞医疗科技股份有限公司 前列腺特异性抗原同源异构体化学发光免疫检测试剂盒及其制备方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009111878A1 (en) * 2008-03-11 2009-09-17 Axela Inc. Quantification and affinity characterization of antibodies for the diagnosis of disease using optical diffraction
EP2850432A2 (en) 2012-05-16 2015-03-25 Phadia AB Method for indicating the presence or non-presence of prostate cancer
US10431326B2 (en) 2012-11-20 2019-10-01 Phadia Ab Method for indicating a presence or non-presence of aggressive prostate cancer
CN104007256A (zh) * 2013-02-21 2014-08-27 林斯 总psa和游离psa二合一化学发光免疫诊断试剂盒的制备方法
FI3117216T3 (fi) 2014-03-11 2023-04-27 Phadia Ab Menetelmä kiinteäkasvaimisen syövän tunnistamiseksi
WO2018141828A1 (en) 2017-02-01 2018-08-09 Phadia Ab Method for indicating a presence or non-presence of prostate cancer in individuals with particular characteristics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7659073B2 (en) * 1997-04-30 2010-02-09 Hybritech Incorporated Forms of prostate specific antigens and methods for their detection
AU739546B2 (en) * 1997-04-30 2001-10-18 Hybritech Incorporated Forms of prostate specific antigen and methods for their detection
US7211397B2 (en) * 1999-04-30 2007-05-01 Beckman Coulter, Inc. Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
DE50110712D1 (de) * 2000-05-24 2006-09-21 Roche Diagnostics Gmbh Antikörper gegen spezielle formen des propsa und deren verwendung in immunoassays

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103134929A (zh) * 2011-12-02 2013-06-05 沃克(天津)生物科技有限公司 游离前列腺特异抗原与总前列腺特异抗原一体化酶联免疫检测试剂盒及检测方法
CN102520161A (zh) * 2012-01-05 2012-06-27 中南大学 一种用于spr双通道法检测前列腺特异性抗原的生物传感芯片、试剂盒，检测方法
CN105929151A (zh) * 2016-06-30 2016-09-07 深圳市亚辉龙生物科技股份有限公司 前列腺特异性抗原同源异构体化学发光免疫检测试剂盒及其制备方法
WO2018000896A1 (zh) * 2016-06-30 2018-01-04 深圳市亚辉龙生物科技股份有限公司 前列腺特异性抗原同源异构体化学发光免疫检测试剂盒及其制备方法
CN111596060A (zh) * 2020-05-19 2020-08-28 迪瑞医疗科技股份有限公司 前列腺特异性抗原同源异构体化学发光免疫检测试剂盒及其制备方法

Also Published As

Publication number Publication date
EP1506401A2 (en) 2005-02-16
JP2006508332A (ja) 2006-03-09
US20030219840A1 (en) 2003-11-27
EP1506401A4 (en) 2006-08-23
WO2003100079A2 (en) 2003-12-04
WO2003100079A3 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
US20200200753A1 (en) Methods and kits for detecting prostate cancer biomarkers
US20240133889A1 (en) Use of he4 and other biochemical markers for assessment of ovarian cancers
US20120022793A1 (en) Biomarkers for the diagnosis of prostate cancer in a non-hypertensive population
US20120021925A1 (en) Diagnostic assays for prostate cancer using psp94 and psa biomarkers
CN101023349A (zh) 用于卵巢癌的生物标记
US7211397B2 (en) Method of analyzing non-complexed forms of prostate specific antigen in a sample to improve prostate cancer detection
EP1605266B1 (en) Urothelial cancer tumor marker
CN1656379A (zh) 分析血清中酶原形式的前列腺特异抗原以提高前列腺癌检测的方法
JP2008509379A (ja) 活性化可能な遊離型ｐｓａの検出方法、並びに、前立腺の良性病状及び前立腺ガンの診断におけるその使用
AU2019301756B2 (en) Methods for differentiating benign prostatic hyperplasia from prostate cancer
JPWO2006098464A1 (ja) 前立腺がんの診断方法
WO2011126482A1 (en) Immunoassay for the diagnosis of prostate cancer
WO2008054763A2 (en) Biomarkers for breast cancer
JP2002538433A (ja) 前立腺ガンの病期分類
Barman et al. Design, characterization, and validation of a high-affinity synthetic peptide as bioreceptor for label-free detection of prostate specific antigen
EP3102600B1 (en) Composition and method for detecting malignant neoplastic disease
JP2014025868A (ja) がん転移マーカーおよびそれを用いた診断
CA2747184A1 (en) Biomarkers for the diagnosis of prostate cancer in a non-hypertensive population
JP6312141B2 (ja) 前立腺がん検査用尿中バイオマーカー
Schmitt et al. BTA TRAK™-A USEFUL DIAGNOSTIC TOOL IN URINARY BLADDER CANCER?
WO2005114202A2 (en) Method for diagnosis of prostate cancer
US20090325214A1 (en) Nuclear matrix protein alterations associated with colon cancer and their use as markers for colorectal cancer
HK1225411B (en) Use of he4 and other biochemical markers for assessment of ovarian cancers
HK1225411A (en) Use of he4 and other biochemical markers for assessment of ovarian cancers

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication